A pilot study to assess feasibility of value based pricing in Cyprus through pharmacoeconomic modelling and assessment of its operational framework: sorafenib for second line renal cell cancer

Table 3 Health services use and costs

Parameter	PFS		PD
	Consultation	CT scan	Consultation
Sorafenib	1 specialist visit €40	€256 (every 3 months)	1 GP 2 nurses 1 psychologist €70
Sorafenib	Annual costs related to hypertension: 3 visits € 60	€256 (every 3 months)	1 GP 2 nurses 1 psychologist €70
BSC	1 GP 2 nurses 1 psychologist €70	€256 (every 6 months)	1 GP 2 nurses 1 psychologist €70
Hospitalization (Daily)	€135		€135
Blood test s (Full blood count, liver function SGPT SGOT and creatinine	€157		€157

ISSN: 1478-7547